PRINCETON, N.J.--(BUSINESS WIRE)--Nov. 2, 2016--
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration
company focused on advanced wound and burn care, announced today that it
will hold a conference call on November 10, 2016 to discuss the
financial results for the third quarter of 2016. In addition, management
will provide a business update and a discussion on recent and upcoming
The conference call is scheduled to begin at 11:00 a.m. (Eastern Time).
The results will be released before the opening of the market that same
To access the conference call, U.S.-based listeners should dial
888-563-6275 and international listeners should dial 706-634-7417. All
listeners should provide the following passcode: 11970991. Individuals
interested in listening to the live conference call via the Internet may
do so by logging on to the Company’s website at www.dermasciences.com.
Following the conclusion of the conference call, a replay will be
available through November 16, 2016 and can be accessed by dialing (855)
859-2056 from within the U.S. or (404) 537-3406 from outside the U.S.
All listeners should provide passcode 11970991. The webcast will be
available for 30 days.
About Derma Sciences, Inc.
Derma Sciences is a tissue regeneration company focused on
patent-protected and proprietary advanced wound and burn care
treatments. The Company’s lead products include TCC-EZ®, a gold-standard
total contact casting system for diabetic foot ulcers, and its
MEDIHONEY® product line, the leading brand of honey-based dressings for
the management of wounds and burns. It is also engaged in the
development and commercialization of novel proprietary regenerative
products derived from placental/birth tissues for use in a broad range
of clinical applications including the treatment of complex chronic
wounds, acute wounds and localized areas of injury or inflammation, in
addition to filling soft tissue defects or voids. These products are
used in orthopedic, spinal and ocular surgical procedures, among others.
The Company also offers a full product line of traditional dressings.
For more information, please visit www.dermasciences.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161102006450/en/
Source: Derma Sciences, Inc.
Derma Sciences, Inc.
Executive Chairman and Interim Principal
Sutton Golodetz, 212-838-3777